Biohaven Statistics

Total Valuation

Biohaven has a market cap or net worth of $3.80 billion. The enterprise value is $3.45 billion.

Market Cap	3.80B
Enterprise Value	3.45B

Important Dates

The next estimated earnings date is Thursday, February 27, 2025, after market close.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Biohaven has 101.12 million shares outstanding. The number of shares has increased by 29.45% in one year.

Current Share Class	101.12M
Shares Outstanding	101.12M
Shares Change (YoY)	+29.45%
Shares Change (QoQ)	+7.53%
Owned by Insiders (%)	11.65%
Owned by Institutions (%)	81.69%
Float	84.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	251.42
PB Ratio	11.29
P/TBV Ratio	12.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.09.

Current Ratio	2.89
Quick Ratio	2.52
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -265.45% and return on invested capital (ROIC) is -159.19%.

Return on Equity (ROE)	-265.45%
Return on Assets (ROA)	-118.79%
Return on Capital (ROIC)	-159.19%
Revenue Per Employee	n/a
Profits Per Employee	-$3.37M
Employee Count	239
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-525,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.72% in the last 52 weeks. The beta is 3.93, so Biohaven's price volatility has been higher than the market average.

Beta (5Y)	3.93
52-Week Price Change	-15.72%
50-Day Moving Average	42.40
200-Day Moving Average	41.39
Relative Strength Index (RSI)	45.95
Average Volume (20 Days)	1,199,150

Short Selling Information

The latest short interest is 9.72 million, so 9.61% of the outstanding shares have been sold short.

Short Interest	9.72M
Short Previous Month	7.84M
Short % of Shares Out	9.61%
Short % of Float	11.55%
Short Ratio (days to cover)	9.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-848.89M
Pretax Income	-750.36M
Net Income	-804.34M
EBITDA	-841.60M
EBIT	-848.89M
Earnings Per Share (EPS)	-$9.36

Full Income Statement

Balance Sheet

The company has $378.82 million in cash and $28.99 million in debt, giving a net cash position of $349.83 million or $3.46 per share.

Cash & Cash Equivalents	378.82M
Total Debt	28.99M
Net Cash	349.83M
Net Cash Per Share	$3.46
Equity (Book Value)	316.01M
Book Value Per Share	3.33
Working Capital	288.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$526.59 million and capital expenditures -$4.47 million, giving a free cash flow of -$531.06 million.

Operating Cash Flow	-526.59M
Capital Expenditures	-4.47M
Free Cash Flow	-531.06M
FCF Per Share	-$5.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biohaven does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.45%
Shareholder Yield	-29.45%
Earnings Yield	-21.16%
FCF Yield	-13.97%

Dividend Details

Analyst Forecast

The average price target for Biohaven is $63.00, which is 67.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$63.00
Price Target Difference	67.60%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1